Follow us on Twitter @KU_HE_Lab

Our research group seeks obtaining precise definition and control of immunity at the molecular level to tissue level, via extracellular vesicles and exosomes -mediated delivery and biological programming strategies, which can be employed in advancing cancer immunotherapy, regenerative medicine, and precision therapeutics. The long-standing interest is to understand immunity communication and delivery for translating into novel therapeutics and treatments against cancers, autoimmune diseases, and infectious diseases which immune responses are the central player.